Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

The Journal of antimicrobial chemotherapy ·Vol. 40 ·No. 1 ·1997-07-00 ·Pages 135-6

Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC

Abstract

暂无摘要

MeSH Terms

Aminoglycosides Ampicillin/therapeutic use Anti-Bacterial Agents/therapeutic use Dibekacin/analogs & derivatives,therapeutic use Drug Therapy, Combination/therapeutic use Humans Infant Male Methicillin Resistance Microbial Sensitivity Tests Pulmonary Atresia/complications,surgery Staphylococcal Infections/drug therapy Staphylococcus aureus/drug effects Sulbactam/therapeutic use Vancomycin/pharmacology,therapeutic use Wounds and Injuries/microbiology

Chemicals

Aminoglycosides Anti-Bacterial Agents Dibekacin Vancomycin Ampicillin arbekacin Sulbactam

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Hiramatsu K

Hanaki H

Ino T

Yabuta K

Oguri T

Tenover F C

Article Info

Journal

The Journal of antimicrobial chemotherapy

Abbr.

J Antimicrob Chemother

ISSN

0305-7453

DOI

10.1093/jac/40.1.135

Published

1997-07-00

Pages

135-6

Language

English

Region

England

NLM ID

7513617

Subset

Corrections

CommentIn

PMID: 9533480

External Links

PubMed source DOI: 10.1093/jac/40.1.135 View journal details

Analysis Services

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Contact

WeChat Official Account